REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 31 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,527,733 | -32.9% | 6,877,000 | -12.0% | 0.45% | -21.8% |
| Q2 2023 | $8,240,172 | -15.4% | 7,818,000 | -1.5% | 0.58% | -15.5% |
| Q1 2023 | $9,735,966 | +7.8% | 7,938,000 | -19.8% | 0.68% | +19.4% |
| Q4 2022 | $9,035,048 | -16.0% | 9,896,000 | -0.1% | 0.57% | -20.6% |
| Q3 2022 | $10,755,000 | +108.6% | 9,910,000 | +120.9% | 0.72% | +132.2% |
| Q3 2021 | $5,155,000 | -1.5% | 4,487,000 | 0.0% | 0.31% | -8.0% |
| Q2 2021 | $5,231,000 | +9.0% | 4,487,000 | +4.7% | 0.34% | -2.3% |
| Q1 2021 | $4,800,000 | – | 4,287,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |